| Authors: |
Ahmed Z; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA. Electronic address: zahmed5@bwh.harvard.edu., Hamouche W; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA., Ahmad SO; Department of Medicine, Lowell General Hospital, Lowell, MA., Yu J; Department Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Chowdhury R; Division of Renal Medicine, Mass General Brigham, Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA., Gupta S; Division of Renal Medicine, Mass General Brigham, Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA., Sullivan D; Department of Pharmacology, Dana-Farber Cancer Institute, Boston, MA., Duffy C; Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA., Ahmad S; Gynecologic Oncology Program, Advent Health Cancer Institute, Orlando, FL., Anderson KC; Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA., Laubach J; Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA., Jacobson C; Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA., Nadeem O; Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA. |
